Biophytis (Biophytis) Total Stockholders Equity : $-4.21 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Biophytis Total Stockholders Equity?

Biophytis's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-4.21 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Biophytis's Book Value per Share for the quarter that ended in Dec. 2023 was $-16.17. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Biophytis's Debt-to-Equity for the quarter that ended in Dec. 2023 was -1.58.

Biophytis Total Stockholders Equity Historical Data

The historical data trend for Biophytis's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Total Stockholders Equity Chart

Biophytis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

-9.17

2.80

6.59

-1.99

-4.21

Biophytis Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															6.59	3.16	-1.99	-3.60	-4.21

Biophytis (OTCPK:BPTSY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Biophytis's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-4.206	-	0)	/	0.26012
	=	-16.17

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Biophytis's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.839	+	2.793)	/	-4.206
	=	-1.58

Biophytis Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Biophytis's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biophytis (Biophytis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (OTCPK:BPTSY) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ALBPS:France 6XB:Germany

Address

BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005

Website

https://www.biophytis.com

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.